LexaGene’s technology was originally designed for pathogen detection across very large markets – I’m thrilled to report that we are working to expand our technology’s capability to include cancer diagnostics and Next Generation Sequencing
Submitted June 26, 2018 at 11:07AM by TrueInvestor https://ift.tt/2lAlN2D
No comments:
Post a Comment